29-04-2025 20:34 via medpagetoday.com

Ozempic Blindness Lawsuit; CGM Integrates With Epic; Microdosing GLP-1 Meds

(MedPage Today) -- A Maryland man with diabetes is suing Novo Nordisk, alleging that semaglutide (Ozempic, Wegovy) made him blind due to nonarteritic anterior ischemic optic neuropathy. (NBC News)
In a large study of diabetes, heart failure, or...
Read more »

Medical Industry news



Addressing Disparities in Multiple Sclerosis Treatment
Subcutaneous ICD Ekes Out Favorable Safety Signals 8 Years Into PRAETORIAN Trial
Focused Ultrasound Matches Prostatectomy for Intermediate-Risk Prostate Cancer
U.S. Maternal Death Rate Rose Slightly Last Year, Health Officials Say
FDA Approves Nipocalimab for Adult and Pediatric Myasthenia Gravis
Immunotherapy/BCG Combo Boosts EFS in Non-Muscle Invasive Bladder Cancer
Topical Gel Soothes Skin Rash for CRC Patients on EGFR Inhibitors
DOGE Has Vast HHS Access; 'Thrifty' Tech Exec to Lead Medicare; WHI Still in Limbo
International Doctors Forgo U.S. Medical Meetings, Citing Detention Fears
Bread Recall for Glass; RFK Jr. on Vaccines: 'Do Your Own Research'; Plastic and CVD
Decision Looming for Trump Administration on First PFAS Drinking Water Limits
Alzheimer's Prevalence Tops 7 Million for the First Time
FDA OKs New Gene Therapy for Debilitating Skin Condition
RA Doesn't Diminish Checkpoint Inhibitors' Survival Benefit
Desktop versie